Jazz Pharmaceuticals Public Limited Company是一家公众有限责任公司,根据爱尔兰法律于2005年3月成立。爵士制药公司是一家专业制药公司,专注于医药产品的识别、开发和商业化,以满足巨大的医疗需求。 自2003年建立以来,它已经建立了一个商业和发展组织,组装的产品和候选产品目前包括两种在售产品,以及正处在临床开发的各个阶段的候选产品。它目前销售两种产品: Xyrem (羟丁酸钠) ,这是经美国食品和药物管理局(FDA)唯一批准的治疗嗜睡引起的猝倒证和白天过度嗜睡的产品;兰释CR (马来酸氟伏沙明)用于强迫症的治疗。公司通过其经验丰富的专业销售队伍:睡眠专家、神经病学家、肺科和精神科医生促进这些产品在美国销售。
董事
名称
职位
Renee Gala
President, Chief Executive Officer and Director
Anne O'Riordan
Independent Director
Bruce C. Cozadd
Chairperson of the Board
Heather Ann McSharry
Independent Director
Jennifer E. Cook
Independent Director
Kenneth W. O'Keefe
Independent Director
Laura J. Hamill
Independent Director
Mark D. Smith
Independent Director
Norbert G. Riedel
Independent Director
Patrick G. Enright
Independent Director
Patrick Thomas Kennedy
Independent Director
Rick E Winningham
Lead Independent Director
Seamus C. Mulligan
Independent Director
股东
名称
职位
Renee Gala
President, Chief Executive Officer and Director
Liz Henderson
Senior Vice President, Technical Operations
Patricia Carr
Senior Vice President and Chief Accounting Officer
Philip L. Johnson
Executive Vice President and Chief Financial Officer
Neena M. Patil
Executive Vice President and Chief Legal Officer
Robert Iannone
Executive Vice President, Global Head of Research and Development and Chief Medical Officer
Samantha Pearce
Executive Vice President and Chief Commercial Officer